Comparison of adjusted-dose vs standard-dose OKT3 therapy of acute rejection in pediatric kidney transplant recipients.
Piatosa
B
B
Department of Dialysis and Kidney Transplantation, Child Health Centre, Warsaw, Poland.
Grenda
R
R
Prokurat
S
S
D001706:Biopsy; D002648:Child; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000473:pathology / Q000628:therapy*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D016853:Muromonab-CD3 / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012189:Retrospective Studies
D016853:Muromonab-CD3